In a commentary published in the American Journal of Kidney Diseases, public health researchers suggest adjustments to recently proposed rule changes on how Medicare pays for dialysis services.
Medicare spends approximately $35 billion annually on care for beneficiaries with end-stage renal disease (kidney failure), more than 7 percent of Medicare’s total paid claims. Over half a million people receive regular dialysis treatments to manage this condition, with treatment costs averaging about $85,000 a year, according to the study.
